Jinan Liangfu Jinghe Pharmaceutical Technology Co., Ltd.
MAILBOX | CHINESE | ENGLISH
Products
API & Intermediates
Cell Signaling Pathway Inhibitors
·Inhibitors of BTK Pathway
·Inhibitors of EGFR pathways
·Inhibitors of VEGFR pathways
·Inhibitors of PDGFR pathways
·Inhibitors of PI3K-Akt-mTOR pathways
·Inhibitors of IGF pathways
·Inhibitors of JAK-STAT pathway
·Inhibitors of MAPK/ERK pathway
·Inhibitors of apoptosis pathway
·Inhibitors of HIF-1 pathway
·Inhibitors of other pathways
Small Molecule Compounds
Impurity Reference Standards
Others
Contact Us
Address: 2766 Yingxiu Road, Jinan High-Tech Zone, China
Tel:
Sales: +86-531-88811783
Evaluation:+86-531-88806178
R&D: +86-531-88813691
Office: +86-531-88817621
Fax: +86-531-88817925
Zip Code: 250101
Email:
Trade Department:
sales@trio-pharmatech.com
G&D&E:
register@trio-pharmatech.com
yzxpj@trio-pharmatech.com
R&D center::
newdrugs@trio-pharmatech.com
Cell Signaling Pathway Inhibitors Now Position:Home > Products > Cell Signaling Pathway Inhibitors < Inhibitors of other pathways
AP26113(CAS:1197958-12-5)

Product No.

TP1132A

Name

AP26113

Synonyms

5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine

CAS Number

1197958-12-5

Structure

Brief Description

AP26113 is a potent ALK inhibitor with IC50 of 0.62 nM, demonstrated ability overcome Crizotinib resistance mediated by a L1196M mutation. Phase 2.

Purity

>99%

Package

5mg10mg20mg50mg

 





Close
QQ1: 1762738062
QQ2: 1919147143
MSN: sales-trio
SKYPE: janisa.yan